NCT05363072
- Conditions
- Adenocarcinoma, Cancer of Kidney, Cancer of the Kidney, +19 more
- Locations
-
- Pfizer Finland Helsinki, Finland
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT01210482
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Kyusyu University Hospital Fukuoka, Fukuoka PREF, Japan
NCT03108066
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT05485896
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Changyi Quan Tianjin, Tianjin Municipality, China
NCT04375150
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Pfizer INC New York, United States
NCT02301117
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
- Locations
-
- Phoenix Clinical Site Phoenix, Arizona, United States
- Duarte Clinical Site Duarte, California, United States
- Santa Monica Clinical Site Santa Monica, California, United States
- Gainesville Clinical Site Gainesville, Florida, United States
NCT03334344
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- John Wayne Cancer Institute at Providence St. John's Heath Center Santa Monica, California, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
NCT03693612
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +33 more
- Locations
-
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
Completed
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
NCT00554515
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Tampa, Florida, United States
- Research Site Ann Arbor, Michigan, United States
- Research Site New York, United States